Concepedia

Elisha S. Rusch

ES

Statistics

Publications

4

Citations

182

H-Index

4

Active since

2016

Affiliations

Oregon Health & Science University(Current)

UPMC Hillman Cancer Center

Moffitt Cancer Center

Fred Hutch Cancer Center

OHSU Knight Cancer Institute

Elisha S. Rusch is an author at Oregon Health & Science University specializing in oncology, car t cell trials, and immunotherapy.

Publications per year

2016–2020

4

Publications

4

Grading and management of cytokine release syndrome in patients treated with tisagenlecleucel in the JULIET trial

Stephen J. Schuster, Richard T. Maziarz, Elisha S. Rusch et al. · Blood Advances · 2020 · 76 citations · Full text

Life Sciences, Hematology, Oncology +16

Safety and tolerability of pasireotide long-acting release in acromegaly—results from the acromegaly, open-label, multicenter, safety monitoring program for treating patients who have a need to receive medical therapy (ACCESS) study

Maria Fleseriu, Elisha S. Rusch, Eliza B. Geer · Endocrine · 2016 · 50 citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +15

Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trial

Richard T. Maziarz, Stephen J. Schuster, Vadim Romanov et al. · Blood Advances · 2020 · 44 citations · Full text

Medicine, Neurology, Oncology +17

CYTOKINE RELEASE SYNDROME AND NEUROTOXICITY BY BASELINE TUMOR BURDEN IN ADULTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL

Richard T. Maziarz, Stephen J. Schuster, Solveig G. Ericson et al. · Hematological Oncology · 2019 · 12 citations

Pharmacy, Immunology, Oncology +17

1–4 of 4